Weekly Cumulative RSV Vaccination Coverage And Intent, Overall, By Selected Demographics And Jurisdiction, Among Adults 75 And Older And 50-74 Years With High-Risk Conditions Ever Vaccinated, United States

• Weekly Cumulative RSV Vaccination Coverage and Intent Among Adults 75 Years and Older and 50-74 Years with High Risk Conditions Ever Vaccinated with RSV Vaccine by Demographic Characteristics and Jurisdiction

• Weekly estimates of RSV vaccination coverage and intent among adults 75 years and older and 50-74 years with high risk conditions are calculated using data from National Immunization Surveys (NIS) – Fall Respiratory Virus Module (NIS–FRVM). The NIS-FRVM is an ongoing random-digit-dial cellular telephone survey of households with adults 18 years and older.

• In June 2025, the Advisory Committee on Immunization Practices (ACIP) voted to recommend that adults aged 50–74 years who are at increased risk for severe RSV disease may receive a single dose of an RSV vaccine. In June 2024, the ACIP voted to recommend a single dose of RSV vaccine for all adults 75 years and older. The data below capture ever receiving a dose of an RSV vaccine by adults 50 years and older.

• The NIS-FRVM data posted on the dashboard below are currently a few days behind the data that are posted on the Respiratory Illnesses Data Channel. This lag is due to the time it takes to review data by geographic and sociodemographic characteristics and summarize the findings.

Tags: nis-acm, vsd, iis, iqvia, rsv vaccination, cms

Last updated: 2026-02-10 19:02:14+00:00